君实生物(01877)公布2025年第一季度业绩,营业收入约5亿元,同比增长31....君实生物(01877)公布2025年第一季度业绩,营业收入约5亿元,同比增长31.46%。归属于上市公司股东的净亏损约2.35亿元,同比收窄17%。基本每股亏损0.24元。报告期内,公司营业收入增长主要来自商业化药品销售收入的增长,其中,核心产品特瑞普利单抗注射液(商品名:拓益/LOQTORZI,产品代号:...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.